European Healthcare Expenditure on Medical Goods (Non Specified by Function) by NPISH Financing Schemes by Country

Analysis reveals substantial differences in per capita healthcare expenditure on medical goods by NPISH financing schemes across Europe. As of 2023, Iceland leads with €50.72, a 3.4% increase from the previous year, indicating steady growth. The United Kingdom follows with €8.07, growing by 4.45%. Estonia shows notable progression with a 9.08% rise. Conversely, Latvia exhibits a striking decline of 21.89%. Switzerland experienced the largest drop at 34.97%. Slovenia exhibits robust growth with a 10.76% increase. Poland, Portugal, and Croatia show modest changes, with slight growth in Poland and Portugal, while Croatia remains stable.

Looking ahead, anticipate increased digital healthcare adoption in Europe, contributing to more NPISH involvement. Economic fluctuations and regulatory changes will further influence expenditure trends, potentially affecting countries differently.